The WACC of All Cosmos Bio-Tech Holding Corp (4148.TW) is 6.7%.
| Range | Selected | |
| Cost of equity | 5.50% - 8.90% | 7.20% |
| Tax rate | 27.40% - 30.60% | 29.00% |
| Cost of debt | 4.00% - 6.70% | 5.35% |
| WACC | 5.1% - 8.3% | 6.7% |
| Category | Low | High |
| Long-term bond rate | 2.0% | 2.5% |
| Equity market risk premium | 6.0% | 7.0% |
| Adjusted beta | 0.58 | 0.84 |
| Additional risk adjustments | 0.0% | 0.5% |
| Cost of equity | 5.50% | 8.90% |
| Tax rate | 27.40% | 30.60% |
| Debt/Equity ratio | 0.18 | 0.18 |
| Cost of debt | 4.00% | 6.70% |
| After-tax WACC | 5.1% | 8.3% |
| Selected WACC | 6.7% | |
The Cost of Equity reflects the return a company needs to deliver to shareholders to justify the risk of investing in its shares. It’s computed using the Capital Asset Pricing Model (CAPM), which blends the risk-free rate, the stock’s beta, and the market risk premium.
This method evaluates the stock’s risk compared to a safe investment and the market’s overall volatility.
Here’s how we figure out the cost of equity for 4148.TW:
cost_of_equity (7.20%) = risk_free_rate (2.25%) + equity_risk_premium (6.50%) * adjusted_beta (0.58) + risk_adjustments (0.25%)
We include the risk adjustments, which range from 0% to 1%, to keep our WACC conservatives, especially for companies traded in developing markets.